Clinical Trial

A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum

Name: A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum — clinical trial record (NCT07444684)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of SHR-1139 Injection in patients with pyoderma gangrenosum.

Trial Details

NCT Number	NCT07444684
Lead Sponsor	Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions	Pyoderma Gangrenosum
Enrollment	20 participants
Start Date	2026-03-05
Primary Completion	2027-06 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-03-03